Update on Testosterone Replacement Therapy in Hypogonadal Men.

Late-onset male hypogonadism has long been recognized as a treatable medical condition; however, misconceptions about the use of testosterone replacement therapy (TRT) have often led urologists away from its more mainstream use. This paper aims to bring the reader up-to-date on the current understanding of TRT, starting with when and who to treat. Various formulations of TRT, each with its own risks and benefits, are also detailed.

Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management.

Introduction: : We assess physicians' ability to accurately predict life expectancies. In prostate cancer this prediction is especially important as it affects screening decisions. No previous studies have examined accuracy in the context of real cases and concrete end points.